DGAP-Adhoc: Fresenius SE & Co. KGaA: Fresenius Helios acquires 43 hospitals from Rhön-Klinikum AG

DGAP-Adhoc: Fresenius SE & Co. KGaA: Fresenius Helios acquires 43 hospitals 
from Rhön-Klinikum AG

Fresenius SE & Co. KGaA  / Key word(s): Mergers & Acquisitions

13.09.2013 00:52

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Fresenius Helios acquires 43 hospitals from Rhön-Klinikum AG

The acquisition will make Fresenius Helios the largest private hospital
operator in Europe, with 117 hospitals across Germany and nearly EUR5.5
billion* in sales.

Fresenius Helios has signed a binding agreement to purchase the majority of
Rhön-Klinikum AG's hospitals, acquiring 43 hospitals with a total of
approximately 11,800 beds as well as 15 outpatient facilities. On the basis
of 2013 pro forma financials, the acquisition is expected to add sales of
approximately EUR2 billion and an EBITDA of approximately EUR250 million.

The University Hospital Giessen and Marburg, the hospitals in Bad Neustadt
(including the Rhön-Klinikum AG headquarters), Bad Berka and Frankfurt/Oder
will remain with Rhön-Klinikum AG.

The acquisition will enable Fresenius Helios to significantly expand its
hospital operations. By extending its presence across the country,
Fresenius Helios will bring the majority of the German population within an
hour's drive of a HELIOS hospital. With this platform, Fresenius Helios
aims to develop innovative, integrated care offerings.

Fresenius Helios and Rhön-Klinikum AG are planning to enter into a
cooperation agreement covering Rhön-Klinikum AG's remaining hospitals.
These hospitals will become part of a network offering innovative care
models across Germany. Public, non-profit and other private hospitals are
welcome to join this network.

The acquisition will create substantial cost synergies totalling
approximately EUR85 million before tax from 2015 onwards. These synergies
will be achieved, for instance, by bundling procurement. Mid-term,
Fresenius Helios expects the newly acquired hospital portfolio to reach the
upper half of the 12-15% EBIT-margin range according to its hospital
development plan.

The purchase price of EUR3.07 billion will be entirely debt-financed. Under
the transaction, Fresenius will not assume any financial debt of
Rhön-Klinikum AG. Group net debt/EBITDA is expected to temporarily exceed
3.0 in 2013* but remain below 3.5, before returning to the upper end of the
2.5 to 3.0 target range in 2014.

Fresenius expects one-time costs of approximately EUR80 million before tax.
The Company expects the acquisition to be accretive to earnings per share
in the first year after closing, excluding one-time costs, and clearly
accretive from the second year onwards including one-time costs.

*pro forma 2013

Fresenius SE & Co. KGaA, 
represented by Fresenius Management SE, 
Board of Management

Bad Homburg v.d.H., September 13, 2013

End of note

13.09.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

Language:     English
Company:      Fresenius SE & Co. KGaA
              Else-Kröner-Straße 1
              61352 Bad Homburg v.d.H.
Phone:        +49 (0)6172 608-2485
Fax:          +49 (0)6172 608-2488
E-mail:       ir-fre@fresenius.com
Internet:     www.fresenius.com
ISIN:         DE0005785604
WKN:          578560 
Indices:      DAX
Listed:       Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
              München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart;
              Terminbörse EUREX
End of Announcement                             DGAP News-Service
Press spacebar to pause and continue. Press esc to stop.